Blood cancer is a group of malignant diseases that affect the blood-forming system, including the bone marrow, blood cells, and the lymphatic system. Some of the most common types of blood cancer include Hodgkin and Non-Hodgkin lymphoma, multiple myeloma, and leukemia. Treating these conditions requires a comprehensive medical approach supported by high standards of care.
In response to this need, Mandaya Royal Puri Hospital has established the Mandaya Blood Cancer Center through a collaboration with the National Cancer Institute Singapore – National University Hospital (NCIS–NUH Singapore). This partnership enables the implementation of clinical protocols and blood cancer treatment standards equivalent to those applied at leading referral hospitals in Singapore.
Contents
Facilities and Services at the Mandaya Blood Cancer Center
The following are some of the leading services and facilities available at the Mandaya Blood Cancer Center:
1. Hematopoietic Stem Cell Transplant (HSCT)
HSCT is one of the flagship services offered, involving the transplantation of stem cells to replace bone marrow damaged by blood cancer with healthy blood-forming cells. This procedure aims to restore blood cell production and improve patients’ quality of life.
2. ICIR/PICIR Facilities (Immunocompromised Rooms)
To support the success of HSCT, Mandaya Royal Puri Hospital provides ICIR/PICIR facilities—specialized inpatient rooms designed for patients with weakened immune systems following transplantation. These rooms help minimize the risk of infection during the recovery period.
3. Irradiated Blood Transfusion
The Mandaya Blood Cancer Center offers irradiated blood transfusion services to prevent serious complications such as Transfusion-Associated Graft-Versus-Host Disease (TA-GvHD). This service is especially important for blood cancer patients who have undergone stem cell transplantation.
4. Comprehensive Systemic Therapy
A full range of systemic therapies is available, including chemotherapy, immunotherapy, targeted therapy, and radiotherapy. Each treatment plan is tailored to the type of blood cancer and the patient’s individual clinical condition.
5. Digital PET/CT Scan
To support diagnosis and therapy evaluation, Mandaya Royal Puri Hospital utilizes Digital PET/CT Scan technology. This examination allows physicians to map the location, metabolic activity, and spread of cancer cells with greater accuracy and detail.
6. Flow Cytometry Examination
Advanced diagnostic tests such as flow cytometry are performed to analyze the characteristics of blood cancer cells and assess the effectiveness of ongoing treatments.
7. Apheresis Services
As part of its integrated services, Mandaya Royal Puri Hospital provides apheresis procedures to reduce abnormal blood components, such as excessive white blood cells in leukemia patients. This procedure helps control symptoms more rapidly based on clinical needs.
KHOM Medical Team at the Mandaya Blood Cancer Center
Consultant Medical Hematology-Oncology Specialists (KHOM) are subspecialists with advanced expertise in diagnosing and treating blood cancers. Mandaya Royal Puri Hospital is supported by five experienced KHOM specialists who manage lymphoma, leukemia, and multiple myeloma cases.
1. dr. Toman T.J. Lumban Toruan, Sp.PD-KHOM
Dr. Toman T.J. Lumban Toruan, Sp.PD-KHOM, is an internal medicine specialist with a subspecialty in Medical Hematology-Oncology, a graduate of the Faculty of Medicine, University of Indonesia, and Dr. Cipto Mangunkusumo Hospital. He also completed an Honorary Fellowship (Clinical Observership) at the Department of Hematology, NUH Singapore.
His expertise includes chemotherapy, immunotherapy, targeted therapy, and apheresis procedures.
Practice schedule at Mandaya Royal Puri Hospital:
- Tuesday: 12.00 – 15.00 WIB
- Thursday: 12.00 – 15.00 WIB
2. dr. Alvin Tagor Harahap, Sp.PD-KHOM
Dr. Alvin Tagor Harahap, Sp.PD-KHOM, completed his medical and internal medicine specialist training at the Faculty of Medicine, University of Indonesia. He has extensive experience in treating blood cancer and various hematological disorders using a comprehensive medical approach.
Practice schedule at Mandaya Royal Puri Hospital:
- Wednesday: 18.00 – 20.00 WIB
- Saturday: 10.00 – 12.00 WIB
3. Prof. DR. Aru W. Sudoyo, Sp.PD-KHOM, FINASIM, FACP
Prof. DR. Aru W. Sudoyo, Sp.PD-KHOM, FINASIM, FACP, is a prominent figure in hematology and oncology in Indonesia. His expertise includes advanced cancer therapies such as chemotherapy, immunotherapy, targeted therapy, bone marrow transplantation, and CAR-T cell therapy.
Practice schedule at Mandaya Royal Puri Hospital:
- Wednesday: 08.00 – 12.00 WIB
4. Dr. dr. Andree Kurniawan, Sp.PD-KHOM, FINASIM
Dr. dr. Andree Kurniawan, Sp.PD-KHOM, FINASIM, has extensive experience in managing blood cancer with a personalized approach focused on patients’ clinical needs, including chemotherapy, immunotherapy, and targeted therapy.
Practice schedule at Mandaya Royal Puri Hospital:
- Monday: 17.00 – 19.00 WIB
- Thursday: 17.00 – 19.00 WIB
5. dr. Nia Noviantri Siregar, Sp.PD, Subsp. H-Onk.M (K)
Dr. Nia Noviantri Siregar, Sp.PD, Subsp. H-Onk.M (K), focuses on the treatment of blood cancer and complex hematological disorders using approaches based on the latest medical advancements.
Practice schedule at Mandaya Royal Puri Hospital:
- Tuesday: 17.00 – 20.00 WIB
- Friday: 17.00 – 20.00 WIB
Mandaya–NUH Singapore Collaboration for More Precise Blood Cancer Care
The Blood Cancer Center at Mandaya Royal Puri Hospital has established a strategic collaboration with NCIS–NUH Singapore to deliver more precise blood cancer care. This partnership includes cross-border multidisciplinary case discussions, allowing each patient to be comprehensively evaluated by medical teams from both institutions.
Through this collaboration, diagnostic accuracy, treatment effectiveness, and therapy selection can be optimally tailored to each patient’s individual condition. Patients also gain access to second opinions directly from internationally experienced blood cancer specialists.
Erwin Suyanto, Public Relations Manager of Mandaya Hospital Group, stated that the establishment of the Mandaya Blood Cancer Center reflects Mandaya Royal Puri Hospital’s commitment to providing comprehensive, integrated, and globally standardized cancer care.
With the support of comprehensive medical facilities and close collaboration with NCIS–NUH Singapore, Mandaya Royal Puri Hospital continues to strengthen its role as an international-standard cancer referral hospital in Indonesia.
If you would like to undergo a health check-up at Mandaya Royal Puri Hospital, you can use the WhatsApp chat feature, Book Appointment, or the Care Dokter application, available on Google Play and the App Store, to make your visit easier, check queue numbers, and access complete information.
